Metabolic pathways regulate cardiovascular toxicity in cancer immunotherapy
Cancer Letters · 2026
DOI: 10.1016/j.canlet.2026.218531 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2026. Verfasst von Zeying Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, PR China. Electronic address: zeyingli@stu.njmu…. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Cardiotoxicity, Metabolic Networks and Pathways. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Graduate Research and Innovation Projects of Jiangsu Province, Major Research Plan of National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, yet their clinical application is constrained by a critical trade-off between potent antitumor efficacy and off-target cardiovascular toxicity. This adverse effect underscores a fundamental biological dilemma: how tumor immunotherapy disrupts cardiovascular homeostasis. Immune cells within the cardiovascular system undergo metabolic adaptations after immune therapy. This intricate crosstalk has brought metabolic checkpoints to the forefront of research. In this review, we systematically outline the features of tumor-associated metabolic remodeling and shared roles in cardiac metabolism and immunometabolism. We elucidate ICIs initiate a cascade of events leading to cardic dysfunction through metabolic signal pathways. Furthermore, we propose that the strategic integration of cutting-edge technologies including spatial metabolomics to enable precise reprogramming of metabolic networks will ultimately decouple the efficacy of cancer immunotherapy from its associated toxicities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, PR China. Electronic address: zeyingli@stu.njmu.edu.cn.
- Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, PR China. Electronic address: yzyhyxssyangkai@163.com.
- Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, PR China. Electronic address: fangli-j@pku.edu.cn.
- Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, PR China. Electronic address: meijie1996@njmu.edu.cn.
- Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, PR China. Electronic address: drtianyu@njmu.edu.cn.
- Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, PR China. Electronic address: 15161125008@163.com.
Förderung
- Graduate Research and Innovation Projects of Jiangsu Province
- Major Research Plan of National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Li, Z., Yang, K., Jiang, F., Mei, J., Zeng, T., Zhao, X., Liang, Y., Huang, X., & Yin, Y. (2026). Metabolic pathways regulate cardiovascular toxicity in cancer immunotherapy. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218531
Vancouver
Li Z, Yang K, Jiang F, Mei J, Zeng T, Zhao X, et al. Metabolic pathways regulate cardiovascular toxicity in cancer immunotherapy. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218531
BibTeX
@article{Li2026,
author = {Li, Zeying and Yang, Kai and Jiang, Fangli and Mei, Jie and Zeng, Tianyu and Zhao, Xiwen and Liang, Yan and Huang, Xiang and Yin, Yongmei},
title = {Metabolic pathways regulate cardiovascular toxicity in cancer immunotherapy},
journal = {Cancer Letters},
year = {2026},
doi = {10.1016/j.canlet.2026.218531}
}
EUVIMED